Atlas Trials

Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test

Clinical trial NCT04958109 · COMPLETED

Trial details

NCT number
NCT04958109
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metabolic Diseases
Start date
2021-10-28
Primary completion
2022-10-31
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.